文献速递骨显像与常规 SPECT放射性药物与辐射防护

基于万古霉素的示踪剂引导骨接合装置上细菌的原位可视化与手术清创

Vancomycin-based tracers guiding in situ visualization of bacteria on osteosynthesis devices and surgical debridement.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-04-02

研究在离体人胫骨与股骨上固定覆盖细菌生物膜并用[18F]PQ-VE1-万古霉素和/或万古霉素-IRDye800CW预孵育的接骨板,用PET/CT与荧光成像定量清创前后细菌负荷。清创前生物膜覆盖接骨板的示踪剂摄取较无生物膜接骨板显著高2.2倍(p < 0.001),清创后PET信号微弱,荧光引导手术可实时显示并去除生物膜。

要点

  • 离体骨上生物膜覆盖接骨板的PET示踪剂摄取较无生物膜接骨板高2.2倍(p < 0.001)。
  • 清创后PET信号微弱,提示生物膜被有效去除。
  • 荧光引导手术可实时显示并去除细菌生物膜。

核心结论

  • 基于万古霉素的示踪剂联合术前PET与术中荧光成像,可实现无创检测与实时感染管理,如这些初步发现所示。

研究设计与样本

  • 在离体人胫骨与股骨上固定覆盖细菌生物膜并以[18F]PQ-VE1-万古霉素和/或万古霉素-IRDye800CW预孵育的接骨板。
  • 使用PET/CT与荧光成像定量手术清创前后的细菌负荷。

主要发现

  • 清创前,生物膜覆盖接骨板的PET示踪剂摄取较无生物膜接骨板显著高2.2倍(p < 0.001)。
  • 清创后PET信号微弱,表明生物膜被有效去除。
  • 荧光引导手术实现了细菌生物膜的实时可视化与去除。

关键数值与推荐

  • 清创前生物膜覆盖接骨板较无生物膜接骨板的PET示踪剂摄取高2.2倍(p < 0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文称这些为初步发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Bacterial infections associated with musculoskeletal injuries are challenging to detect and distinguish from sterile inflammation. Here we present the combined first-time application of a bacteria-targeted positron emission tomography (PET) tracer and a near-infrared fluorescent tracer to detect infected osteosynthesis implants and guide surgical treatment. METHODS: To this end, osteosynthesis plates covered with bacterial biofilm and pre-incubated with [18F]PQ-VE1-vancomycin for PET imaging and/or vancomycin-IRDye800CW for optical imaging were fixed to post-mortem human tibiae and femora. PET/CT and fluorescence imaging were used to quantify the bacterial load before and after surgical debridement. RESULTS: Pre-debridement, PET imaging showed a significant 2.2-fold higher tracer uptake on biofilm-covered plates compared to plates without biofilm (p < 0.001). Post-debridement, the PET signal was marginal, demonstrating effective biofilm removal. Fluorescence-guided surgery enabled real-time visualization and removal of bacterial biofilms. CONCLUSION: Combined preoperative PET and intraoperative fluorescence imaging with vancomycin-based tracers allows noninvasive detection and real-time infection management, as demonstrated by these preliminary findings.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Spoelstra GB, Elsinga PH, van Dijl JM, et al. Vancomycin-based tracers guiding in situ visualization of bacteria on osteosynthesis devices and surgical debridement. Eur J Nucl Med Mol Imaging. 2025. PMID: 40172692. doi:10.1007/s00259-025-07249-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。